Decreased Seizure Activity in a Human Neonate Treated With Bumetanide,an Inhibitor of the Na + -K + -2Cl

Abstract

Neonatal seizures have devastating consequences for brain development and are inadequately treated by available antiepileptics. In neonates, g-aminobutyric acid (GABA) is an excitatory neurotransmitter due to elevated levels of intraneuronal chloride achieved by robust activity of the Na⁺-K⁺-2Cl^- cotransporter (NKCC1). This depolarizing action of GABA likely contributes to the lowered seizure threshold, increased seizure propensity, and poor efficacy of GABAergic anticonvulsants among infants. The diuretic bumetanide inhibits NKCC1 and silences seizure activity in rodent models of neonatal seizures, but its effect on seizures in human neonates is unknown. Continuous electroencephalography (EEG) monitoring was used to quantify the number, duration, and frequency of seizures 2 hours before and after the administration of bumetanide in a neonate with intractable multifocal seizures. Significant reductions in mean seizure duration and frequency were noted following treatment, with no associated clinical side effects or metabolic imbalances. These results suggest bumetanide may exert antiepileptic effects in human neonates.

Keywords

neonatal seizures bumetanide Na+-K+-2Cl- cotransporter NKCC1

Get full access to this article

View all access options for this article.

References

Ben-Ari Y. , Holmes GL Effects of seizures on developmental processes in the immature brain. Lancet Neurol. 2006 ;5(12):1055-1063.

Boylan GB , Rennie JM , Pressler RM , Wilson G. , Morton M. , Binnie CD Phenobarbitone, neonatal seizures, and video-EEG. Arch Dis Child Fetal Neonatal Ed. 2002;86:F165-F170.

Castro-Conde JR , Hernández-Borges AA , DoménechMartínez E. , González Campo C. , Perera Soler R. Midazolam in neonatal seizures with no response to phenobarbital. Neurology . 2005;64:876-879.

Painter MJ , Scher MS , Stein AD , et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med. 1999;341:485-489.

Ben-Ari Y. Excitatory actions of GABA during development: the nature of the nurture. Nat Rev Neurosci. 2002;3:728-739.

Dzhala VI , Talos DM , Sdrulla DA , et al. NKCC1 transporter facilitates seizures in the developing brain . Nat Med. 2005;11:1205-1213.

Khalilov I. , Holmes GL , Ben-Ari Y. In vitro formation of a secondary epileptogenic mirror focus by interhippocampal propagation of seizures. Nat Neurosci. 2003 ;6:1079-1085.

Connell J. , Oozeer R. , de Vries L. , Dubowitz LM , Dubowitz V. Clinical and EEG response to anticonvulsants in neonatal seizures. Arch Dis Child. 1989;64:459-464.

Scher MS , Alvin J. , Gaus L. , Minnigh B. , Painter MJ Uncoupling of EEG-clinical neonatal seizures after antiepileptic drug use . Pediatr Neurol. 2003;28:277-280.

10.

Kahle KT , Staley KJ , Nahed B. , et al. Roles of the cation-chloride cotransporters in neurological disease. Nat Clin Pract Neurol. 2008;9:490-503.

11.

Kahle KT , Staley KJ The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures. Neurosurg Focus. 2008;25(3):E22-E27.

12.

Dzhala VI , Brumback AC , Staley KJ Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol. 2008;63:222-235.

13.

Lopez-Samblas AM , Adams JA , Goldberg RN , Modi MW The pharmacokinetics of bumetanide in the newborn infant. Biol Neonate. 1997;72:265-272.

14.

Sullivan JE , Witte MK , Yamashita TS , Myers CM , Blumer JL Pharmacokinetics of bumetanide in critically ill infants. Clin Pharmacol Ther. 1996;60:405-413.

15.

Clancy RR Prolonged electroencephalogram monitoring for seizures and their treatment . Clin Perinatol. 2006;33:649-665.

16.

Payne JA , Rivera C. , Voipio J. , Kaila K. Cation-chloride cotransporters in neuronal communication, development and trauma. Trends Neurosci. 2003;26:199-206.

17.

Delpire E. Cation-chloride cotransporters in neuronal communication. News Physiol Sci. 2000;15:309-312.

18.

Gamba G. Molecular physiology and pathophysiology of electro-neutral cation-chloride cotransporters. Physiol Rev. 2005;85:423-493.

19.

Hannaert P. , Alvarez-Guerra M. , Pirot D. , Nazaret C. , Garay RP Rat NKCC2/NKCC1 cotransporter selectivity for loop diuretic drugs. Naunyn Schmiedebergs Arch Pharmacol . 2002;365: 193-199.

20.

Isenring P. , Forbush B. Ion transport and ligand binding by the NA-K-Cl cotransporter, structure-function studies. Comp Biochem Physiol A Mol Integr Physiol. 2001;130:487-497.

21.

Sipila ST , Schuchmann S. , Voipio J. , Yamada J. , Kaila K. The cation-chloride cotransporter NKCC1 promotes sharp waves in the neonatal rat hippocampus. J Physiol. 2006;573:765-773.

22.

Ge S. , Goh EL , Sailor KA , Kitabatake Y. , Ming GL , Song H. GABA regulates synaptic integration of newly generated neurons in the adult brain. Nature. 2006;439:589-593.

23.

Cancedda L. , Fiumelli H. , Chen K. , Poo MM Excitatory GABA action is essential for morphological maturation of cortical neurons in vivo. J Neurosci. 2007;27(19):5224-5235.

24.

Wang DD , Kriegstein AR GABA regulates excitatory synapse formation in the neocortex via NMDA receptor activation. J Neurosci. 2008;28(21):5547-5558.

25.

Holmes GL , Ben Ari Y. Seizures in the developing brain: perhaps not so benign after all. Neuron. 1998;21:1231-1234.

26.

Sifringer M. , Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann N Y Acad Sci. 2003;993:103-114.

Decreased Seizure Activity in a Human Neonate Treated With Bumetanide,an Inhibitor of the Na + -K + -2Cl - Cotransporter NKCC1

Abstract

Keywords

Get full access to this article

References